Report Interpretation
Covering the latest research from top Wall Street investment banks
Report InterpretationHilo Research

Wuliangye (000858): Nomura initiates Wuliangye at Neutral as channel destocking progresses but demand recovery remains gradual

Nomura sees Wuliangye retaining a strong position in premium baijiu and expects channel inventories to normalize, supporting a recovery in core-product volume and pricing. It sets a CNY73.59 target price, implying 6.8% upside, but remains Neutral amid weak end-demand and pressure on non-core liquor products.

InstitutionNomura
Date20260929
CompanyWuliangye
Ticker000858.SZ
IndustryPremium baijiu
RatingNeutral

Summary

Nomura sees Wuliangye retaining a strong position in premium baijiu and expects channel inventories to normalize, supporting a recovery in core-product volume and pricing. It sets a CNY73.59 target price, implying 6.8% upside, but remains Neutral amid weak end-demand and pressure on non-core liquor products.

Initiate: Neutral | TP: CNY73.59 | Current price: CNY68.91 | Implied upside: 6.8%
Wuliangyepremium baijiuchannel destockingNeutralP/E valuationChina consumer staples
  • 1H26 Wuliangye-branded baijiu revenue rose 72.8% year-on-year, while 2Q26 total revenue fell 13.2%.
  • Regulated commodities were CNY4.51bn at end-June 2026, down 11.4% year-on-year and 8.2% from end-2025.
  • Nomura forecasts revenue of CNY51.86bn, CNY53.88bn and CNY55.98bn in 2026F-28F.
  • The target price is based on 18x 2026F P/E and 2026F EPS of CNY4.09.

Report Interpretation

Overview

This initiation report examines whether Wuliangye can translate easing channel inventory pressure into a sustained recovery in premium-baijiu sales and pricing. Nomura expects earnings to rebound in 2026F, but sees a gradual demand recovery and maintains a Neutral rating.

Core views

Nomura argues that Wuliangye remains a leading premium-baijiu producer despite soft end-demand and an ongoing channel adjustment. Euromonitor data show it held 12.4% of China's ultra-premium baijiu market in 2025, ranking second and 2.5 percentage points ahead of Jiannanchun. Industry concentration increased, with the top-three share rising from 52.5% in 2021 to 55.3% in 2025. Wuliangye's own share declined 1.1 percentage points year-on-year in 2025 and its gap with Moutai widened to 20.6 percentage points, but Nomura considers its brand recognition and channel strength in the CNY1,000 price band intact. The near-term operating picture is uneven. In 1H26, reported revenue was CNY28.42bn, up 20.9% year-on-year, while net profit rose 89.3% to CNY8.75bn. However, 2Q26 revenue fell 13.2% to CNY5.58bn, which Nomura views as evidence that end-demand remains weak. Profit growth was aided by a more favorable product mix and a lower taxes-and-surcharges ratio. Wuliangye-branded baijiu revenue rose 72.8% to CNY23.63bn in 1H26, with volume up 88.3% to 16kt but ASP down 8.2% to CNY1.451m per tonne. Nomura attributes the volume increase mainly to quota phasing around the Chinese New Year peak season and expansion into emerging channels, rather than a full underlying demand recovery. Channel indicators provide the basis for Nomura's gradual-recovery case. Regulated commodities stood at CNY4.51bn at 30 June 2026, down 11.4% year-on-year and 8.2% from end-2025, which it interprets as progress in destocking. Nomura forecasts Wuliangye-branded baijiu volume growth of 66.9% in 2026F, slowing to 2.0% and 2.3% in 2027F and 2028F as the comparison base rises and underlying demand improves only gradually. It forecasts the segment's ASP to decline 2.8% in 2026F, reflecting a mix weighted toward 8th-Generation Wuliangye and continued pricing flexibility to facilitate destocking, before rising 1.6% and 1.3% in 2027F-28F as inventories normalize and supply-demand conditions improve. The core baijiu segment is expected to account for 87.4%, 87.2% and 87.0% of revenue in 2026F-28F, with gross margin of 85.9%, 86.0% and 86.0%. In contrast, other liquor products remain under pressure: 1H26 revenue fell 60.2% and volume fell 63.8%, as competitor price cuts weighed on the mid-range segment. Nomura forecasts other-liquor volume to decline 65% in 2026F before recovering 4% in each of 2027F and 2028F; gross margin is forecast to remain at 60.0% through 2028F. Non-liquor products are forecast to decline 10% in 2026F before growing 5% annually in 2027F-28F. Nomura expects revenue of CNY51.86bn, CNY53.88bn and CNY55.98bn in 2026F-28F, and net profit of CNY15.87bn, CNY16.45bn and CNY17.39bn. Its 2026F-28F revenue forecasts are 10.6%, 5.5% and 1.0% above Wind consensus, based on a more optimistic view of core-product volume recovery. Its 2026F net-profit forecast is 5.4% above consensus, while 2027F and 2028F forecasts are 2.1% and 6.8% below consensus because it assumes higher selling expenses amid continued competition. Selling expenses are forecast at 23%, 22% and 21% of revenue in 2026F-28F, while the taxes-and-surcharges ratio is assumed to normalize at about 15%. For valuation, Nomura applies 18x 2026F P/E to 2026F EPS of CNY4.09, deriving a CNY73.59 target price and 6.8% implied upside. The target multiple is above the peer average of 16.3x because of Wuliangye's leading premium-baijiu channel position; the stock traded at 16.9x 2026F P/E. Nomura initiates at Neutral, as the valuation and prospective recovery are offset by uncertainty over wholesale-price stabilization, distributor incentives and the pace of end-market demand recovery.

Analysis framework

Nomura reviews 1H26 operating performance by product line, separates volume, ASP and margin drivers, and uses channel inventory data to assess destocking progress. It then forecasts segment revenue and expenses for 2026F-28F, compares estimates with Wind consensus, and values the company using a peer-informed 2026F P/E multiple.

Methodology notes

  • Industry AnalysisVolume-price decomposition

    Segment revenue analysis through sales volume, ASP and gross margin assumptions.

    Nomura explains the outlook for Wuliangye-branded and other liquor products by separating expected shipment volumes, selling-price changes and margins.

  • Valuation methodsP/E and PEG Valuation

    P/E multiple valuation.

    Nomura applies an 18x 2026F P/E multiple to 2026F EPS of CNY4.09 to derive the CNY73.59 target price.

  • Industry AnalysisSupply-demand framework

    Channel inventory and wholesale-price assessment.

    The report links destocking, distributor incentives, wholesale prices and end-market sell-through to the expected recovery in volume and ASP.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Wuliangye (000858.SZ)
    Primary covered premium-baijiu company
    Strengths
    Leading position in the CNY1,000 price band, strong brand recognition and channel strength.
    Weaknesses
    Soft end-demand, declining core-product ASP in 2026F and pressure on other liquor products.
    Comparison
    Its 2025 ultra-premium market share was 12.4%, ranking second; Nomura values it at 18x 2026F P/E versus a 16.3x peer average.
    Risks
    Continued wholesale-price pressure for 8th-Generation Wuliangye and tighter restrictions on business and government-related consumption.
  • Kweichow Moutai (600519 CH)
    Valuation comparable
    Comparison
    Included among Nomura's premium-baijiu peers.
  • Luzhou Laojiao (000568 CH)
    Valuation comparable
    Comparison
    Included among Nomura's premium-baijiu peers.
  • Anhui Gujing Distillery (000596 CH)
    Valuation comparable
    Comparison
    Included among Nomura's premium-baijiu peers.

Key data

  • 1H26 revenueCNY28.42bn, +20.9% y-yReported company revenue.
  • 2Q26 revenueCNY5.58bn, -13.2% y-yNomura cites weak end-demand.
  • 1H26 Wuliangye-branded baijiu revenueCNY23.63bn, +72.8% y-yVolume rose 88.3% to 16kt while ASP fell 8.2%.
  • Regulated commoditiesCNY4.51bnAt 30 June 2026; down 11.4% y-y and 8.2% from end-2025.
  • 2026F-28F revenueCNY51.86bn / CNY53.88bn / CNY55.98bnNomura forecasts.
  • 2026F-28F net profitCNY15.87bn / CNY16.45bn / CNY17.39bnNomura forecasts.
  • Target valuation18x 2026F P/E on CNY4.09 EPSProduces a CNY73.59 target price.

Impact & implications

Nomura's Neutral stance reflects a view that Wuliangye's premium positioning, improving channel inventory and eventual core-product recovery support earnings normalization, while soft demand, wholesale-price risk and sustained market-investment needs limit near-term upside.

Risks

  • Continued pressure on the wholesale price of 8th-Generation Wuliangye could squeeze distributor margins, weaken distributor incentives and weigh on end-market sell-through.
  • Further tightening of regulations on business and government-related consumption could keep premium-baijiu demand under pressure.

What to watch

  • Progress on the CNY8bn-CNY10bn share-repurchase plan.
  • Further channel destocking and changes in regulated-commodity balances.
  • Stabilization or recovery in the wholesale price of 8th-Generation Wuliangye.
  • The pace of macroeconomic recovery, business activity and premium-banquet demand.

Settings

Sign in to view recent logins